Ratings
0
Nobody has rated this yet. Be the first!
Works
5
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.
Treatment of Advanced Prostate Cancer
Development of an integrated prostate cancer research information system.
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
